Titlebook: Hypertrophic Cardiomyopathy; The Therapeutic Role M. Kaltenbach,S. E. Epstein Conference proceedings 1982 Springer-Verlag Berlin Heidelberg

只看該作者 · 發(fā)表于 2025-3-29 02:26:45

Prevention of Myocardial Cell Necrosis in the Syrian Hamster — Results of Long-Term Treatmentnterrelated lines of this disease model the appearance of the cardiomyopathy differs. Contrary to the original strain BIO 14.6, in which the heart developed distinct hypertrophy besides necroses [5, 7, 11–13] the substrains BIO 8262 as well as UM-X 7.1 predominantly display cardiac myolysis, necroti

只看該作者 · 發(fā)表于 2025-3-29 05:11:03

Hemodynamics and Contractility After Oral, Intravenous, and Intracoronary Application of Calcium Antlity remains unaltered presumably due to increased sympathetic activity..The therapeutic effect of verapamil in patients with hypertrophic cardiomyopathy thus may include influences on systolic as well as on diastolic left ventricular function.

只看該作者 · 發(fā)表于 2025-3-29 07:16:57

只看該作者 · 發(fā)表于 2025-3-29 11:38:58

只看該作者 · 發(fā)表于 2025-3-29 19:05:35

只看該作者 · 發(fā)表于 2025-3-29 22:18:44

只看該作者 · 發(fā)表于 2025-3-30 01:08:03

只看該作者 · 發(fā)表于 2025-3-30 04:49:02

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 08:27
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved